PTC Therapeutics, Inc.
USD82.56
+0.99 (+1.22%)
CEO
Matthew Klein
IPO Date
2013-06-20
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$81.71
Prev. Close
$81.57
Day Low
$80.68
Day High
$83.22
52W Low
$43.17
52W High
$87.50
Market Cap
$6.85B
Volume
0.99M
| -9.5 |
| 31 Dec 2023 | FY | 93.0% | -66.8% | 76.6% | -33.1% | -2.72 | 2.02 | -3.3 |
| 31 Dec 2022 | FY | 93.6% | -80.0% | 161.1% | -32.8% | -4.21 | 1.71 | -4.9 |
| 31 Dec 2021 | FY | 94.0% | -97.3% | -36432.6% | -27.0% | 882.73 | 1.87 | -5.4 |
| 31 Dec 2020 | FY | 95.0% | -115.1% | -90.9% | -19.8% | 0.87 | 4.44 | -9.2 |
| 31 Dec 2019 | FY | 96.0% | -82.0% | -42.3% | -15.5% | 0.55 | 3.30 | -11.2 |
| 31 Dec 2018 | FY | 95.2% | -48.4% | -36.5% | -11.4% | 0.44 | 1.92 | -12.5 |
| 31 Dec 2017 | FY | 97.6% | -40.6% | -50.5% | -20.2% | 0.93 | 3.04 | -8.3 |
| 31 Dec 2016 | FY | -42.2% | -171.8% | -118.8% | -52.8% | 0.82 | 5.27 | -2.6 |
| -11.4 |
| 30 Sept 2025 | Q3 | 45.1% | 7.5% | -10.2% | 0.6% | -3.25 | 2.32 | 78.7 |
| 30 Jun 2025 | Q2 | 93.6% | -36.3% | 31.4% | -2.5% | -1.88 | 3.62 | -14.7 |
| 31 Mar 2025 | Q1 | 98.9% | 73.7% | -466.5% | 32.6% | -2.10 | 3.89 | 1.1 |
| 31 Dec 2024 | Q4 | 92.4% | -30.9% | 6.0% | -3.9% | -2.25 | 2.35 | -13.2 |
| 30 Sept 2024 | Q3 | 94.5% | -54.2% | 10.1% | -5.8% | -0.38 | 2.10 | -6.7 |
| 30 Jun 2024 | Q2 | 91.7% | -53.1% | 10.1% | -5.2% | -0.40 | 2.23 | -6.0 |
| 31 Mar 2024 | Q1 | 93.0% | -43.6% | 10.2% | -5.1% | -0.47 | 2.03 | -6.0 |
| 31 Dec 2023 | Q4 | 65.4% | -50.7% | 19.0% | -8.2% | -2.72 | 2.02 | -3.3 |